Transforming the Genetic Toxicology Testing Market in 2025: Driving Factors For Growth Of Genetic Toxicology Testing Market In The Era Of Personalized Medicine

What Is the Expected Size and Growth Rate of the Genetic Toxicology Testing Market?
The market size for genetic toxicology testing has seen rapid expansion in the recent past. The value is expected to increase from $1.63 billion in 2024 to $1.8 billion in 2025, signifying a compound annual growth rate (CAGR) of 10.4%. Several factors contributed to the growth during the historic period, including escalating public health emergencies, the rise of globalization, a heightened emphasis on personalized medication, an increasing necessity for thorough testing methods, and a rising number of drug creations.

The market for genetic toxicology testing is anticipated to experience a swift increase in size in the upcoming years, predicting to hit $2.64 billion by 2029 with a compound annual growth rate (CAGR) of 10.0%. This surge within the predicted period can be traced back to the increased need for novel food testing, heightened worries regarding potential hazards, escalating environmental and health concerns, enhanced regulatory scrutiny, amplified adoption of in vitro testing methods, and the emergence of high-throughput screening platforms. The forecast period will also see a trend in breakthroughs in precision medicine and toxicogenomics, extensive risk communication, methodologies for genetic toxicology testing, risk assessment methods progression, understanding and utilization of omics technologies, and developments in genomics and molecular biology.

What Factors Are Fueling Growth in the Genetic Toxicology Testing Market?
The upward trend in the demand for customized medicine is slated to fuel the upswing in the genetic toxicology testing market. Tailoring healthcare decisions, practices, products, and interventions to suit individual patients based on their anticipated response or disease risk forms the backbone of personalized medicine. A positive surge in the personalized medicine market has been ushered in due to genetic advancements, a deeper understanding of diseases, the incorporation of biomarker-based diagnostics, the initiation of value-based health care, and its integration with clinical practice and research. Genetic toxicology testing, by offering crucial insights into genetic variability, susceptibility to genotoxic agents, and treatment response, plays a significant role in personalized medicine. For instance, as stated by the Personalized Medicine Coalition, a non-profit organization based in the U.S., in February 2024, the FDA sanctioned 16 new personalized medicines for patients with rare diseases in 2023, a considerable escalation from six in 2022. Consequently, this escalating demand for personalized medicine serves as a driving force for the genetic toxicology testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

Which Leading Companies Are Shaping the Growth of the Genetic Toxicology Testing Market?
Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

What Are the Major Trends Shaping the Genetic Toxicology Testing Market?
Key players in the genetic toxicology testing market are focusing their efforts on devising innovative drug screening tools, like phenotypic drug screening, to enhance precision and efficacy in detecting potential genetic toxins. Phenotypic drug screening is a technique employed in drug discovery, evaluating compounds based on their capacity to induce a specific cellular or physiological reaction in a whole organism or an appropriate cell system. For example, Creative Biogene, a biotechnology firm based in the US, introduced zebrafish disease models in August 2022 that aid drug discovery and toxicology research. These models are tailored to emulate human genetic diseases in zebrafish, thereby offering insights into disease causation, drug discovery, and toxicology. The zebrafish models developed by Creative Biogene serve as a crucial platform for examining drug toxicity, forecasting the safety of new compounds, and bolstering the drug development procedure.

What Are the Key Segments of the Genetic Toxicology Testing Market?
The genetic toxicology testing market covered in this report is segmented -

1) By Type: In Vitro, In Vivo
2) By Product: Services, Reagents And Consumables, Assays
3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:
1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods
2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Region Dominates the Genetic Toxicology Testing Market?
North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Genetic Toxicology Testing Global Market Report?

- Market Size Analysis: Analyze the Genetic Toxicology Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Genetic Toxicology Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Genetic Toxicology Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Genetic Toxicology Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.